PRXL2A
Basic information
Region (hg38): 10:80407829-80437115
Previous symbols: [ "C10orf58", "FAM213A" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the PRXL2A gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 17 | 17 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 17 | 0 | 0 |
Variants in PRXL2A
This is a list of pathogenic ClinVar variants found in the PRXL2A region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
10-80420507-A-G | not specified | Uncertain significance (Jul 30, 2023) | ||
10-80420518-T-G | not specified | Uncertain significance (Dec 21, 2022) | ||
10-80420537-G-A | not specified | Uncertain significance (Nov 13, 2024) | ||
10-80420548-G-C | not specified | Uncertain significance (Oct 22, 2021) | ||
10-80422476-G-A | not specified | Uncertain significance (Dec 21, 2023) | ||
10-80425873-C-T | not specified | Uncertain significance (Jan 09, 2024) | ||
10-80425892-A-C | not specified | Uncertain significance (Dec 28, 2022) | ||
10-80425914-G-A | not specified | Uncertain significance (Nov 06, 2023) | ||
10-80427380-A-T | not specified | Uncertain significance (Apr 24, 2023) | ||
10-80427392-G-A | not specified | Uncertain significance (Sep 12, 2023) | ||
10-80427422-G-A | not specified | Uncertain significance (Nov 15, 2024) | ||
10-80427437-A-T | not specified | Uncertain significance (Jul 19, 2022) | ||
10-80427439-C-G | not specified | Uncertain significance (Feb 28, 2024) | ||
10-80431986-G-A | not specified | Uncertain significance (Aug 04, 2024) | ||
10-80432003-C-G | not specified | Uncertain significance (Jul 25, 2023) | ||
10-80432012-A-C | not specified | Uncertain significance (Oct 21, 2024) | ||
10-80432092-A-G | not specified | Uncertain significance (Nov 09, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
PRXL2A | protein_coding | protein_coding | ENST00000372181 | 5 | 25169 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
1.96e-10 | 0.0359 | 125695 | 1 | 52 | 125748 | 0.000211 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.611 | 107 | 126 | 0.847 | 0.00000666 | 1490 |
Missense in Polyphen | 27 | 37.202 | 0.72577 | 414 | ||
Synonymous | -0.0815 | 50 | 49.3 | 1.01 | 0.00000272 | 457 |
Loss of Function | -0.417 | 14 | 12.4 | 1.13 | 7.64e-7 | 128 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000181 | 0.000181 |
Ashkenazi Jewish | 0.000199 | 0.000198 |
East Asian | 0.000109 | 0.000109 |
Finnish | 0.0000462 | 0.0000462 |
European (Non-Finnish) | 0.000168 | 0.000167 |
Middle Eastern | 0.000109 | 0.000109 |
South Asian | 0.000817 | 0.000784 |
Other | 0.000163 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: Involved in redox regulation of the cell (PubMed:26438880, PubMed:19951071). Acts as an antioxidant (PubMed:19951071, PubMed:26438880). Inhibits TNFSF11-induced NFKB1 and JUN activation and osteoclast differentiation (PubMed:19951071). May affect bone resorption and help to maintain bone mass (PubMed:19951071). Acts as a negative regulator of macrophage-mediated inflammation by inhibiting macrophage production of inflammatory cytokines, probably through suppression of the MAPK signaling pathway (PubMed:26438880). {ECO:0000269|PubMed:19951071, ECO:0000269|PubMed:26438880}.;
Recessive Scores
- pRec
- 0.110
Intolerance Scores
- loftool
- rvis_EVS
- -0.01
- rvis_percentile_EVS
- 53.51
Haploinsufficiency Scores
- pHI
- hipred
- N
- hipred_score
- 0.205
- ghis
- 0.489
Essentials
- essential_gene_CRISPR
- essential_gene_CRISPR2
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- gene_indispensability_score
Mouse Genome Informatics
- Gene name
- Fam213a
- Phenotype
- cellular phenotype; homeostasis/metabolism phenotype; adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); immune system phenotype;
Gene ontology
- Biological process
- regulation of osteoclast differentiation;oxidation-reduction process;cellular oxidant detoxification
- Cellular component
- extracellular region;cytoplasm
- Molecular function
- antioxidant activity